EAM-2201 (4′-ethyl-AM-2201 5-fluoro-JWH-210) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature and […]
List of articles in "Drug" category - Page 26
Drisapersen
Drisapersen (also known as PRO051 and GSK2402968) is an experimental drug that was under development by Prosensa for the treatment of Duchenne muscular dystrophy. The drug is a 2′-O-methyl phosphorothioate […]
Crofelemer
Crofelemer (USAN trade name Fulyzaq) is a drug for the treatment of diarrhea associated with anti-HIV drugs such as nucleoside analog reverse transcriptase inhibitors and protease inhibitors.
Resimmune
Resimmune is an experimental anti-T cell immunotoxin that is being investigated for treatment of T cell blood cancers such as cutaneous T cell lymphoma. It was developed by Doctors Neville […]
N-Ethylnorketamine
N-Ethylnorketamine (ethketamine NEK) is a designer drug which is presumed to have similar properties to ketamine a dissociative anesthetic drug with hallucinogenic and sedative effects. It has been sold over […]
S1RA
S1RA E-52862 or 4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine is a selective sigma-1 receptor antagonist with a reported binding affinity of Ki = 17.0 ± 7.0 nM selective over the sigma-2 receptor and against a […]
Aderbasib
Aderbasib (INN/USAN codenamed INCB7839) is a sheddase inhibitor that may suppress tumor cell proliferation. Acting on multiple receptor classes and subclasses aderbasib is observed to regulate the tumor necrosis factor […]
Ameltolide
Ameltolide a 4-aminobenzamide derivative is an experimental anticonvulsant agent effective at inhibiting seizures in animal models. It is non-toxic at dosing levels and no undesirable side effects are attributable to […]
Semax
Semax is a drug produced and prescribed mostly in Russia and Ukraine for a broad range of disorders but predominantly for its purported nootropic neuroprotective and neurorestorative properties. Semax is […]
GLYX-13
GLYX-13 is a nootropic partial agonist of the NMDA receptor – specifically at the glycine binding site. It has been shown to enhance memory and learning in both young adult […]